STOCK TITAN

Amicus Therapeutics, Inc (FOLD) Revenue by Year

FOLD

Amicus Therapeutics, Inc generated $634.2M in revenue in fiscal year 2025. This represents an increase of 20.0% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Amicus Therapeutics, Inc has filed alongside them.

FY2025 annual
Revenue $634.2M
YoY +20.0%
5Y CAGR +19.4%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

FOLD Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$634.2M+20.0%$528.3M+32.3%$399.4M+21.3%$329.2M+7.8%$305.5M+17.1%$260.9M+43.2%$182.2M+99.7%$91.2M+147.1%$36.9M+644.9%$5.0MN/A$1.2M+237.2%$363K-98.0%$18.4M-14.1%$21.4M

FOLD Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Revenue$185.2M+23.7%$169.1M+19.5%$154.7M+22.1%$125.2M+13.4%$149.7M+30.1%$141.5M+36.7%$126.7M+34.0%$110.4M+28.0%$115.1M+30.6%$103.5M+26.7%$94.5M+17.1%$86.3M+9.6%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Amicus Therapeutics, Inc financials

Frequently Asked Questions

What was Amicus Therapeutics, Inc's revenue in fiscal year 2025?

Amicus Therapeutics, Inc generated $634.2M in revenue in fiscal year 2025.

How fast is Amicus Therapeutics, Inc's revenue growing?

Amicus Therapeutics, Inc (FOLD) revenue rose by 20.0% year over year, from $528.3M to $634.2M in fiscal year 2025.

How has Amicus Therapeutics, Inc's revenue changed over the years?

Across the 15 fiscal years this page covers, Amicus Therapeutics, Inc (FOLD) revenue went from $21.4M in fiscal year 2011 to $634.2M in fiscal year 2025.

Amicus Therapeutics, Inc (FOLD) reported $185.2M in revenue in Q4 2025. This represents an increase of 23.7% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Amicus Therapeutics, Inc (FOLD) reported on that line in every period on record.